Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia

Clinical Genetics

Volumn 63, Issue 2, 2003, Pages 135-138

  Al Shali, K ^a,b   Wang, J ^a   Rosen, F ^c   Hegele, Robert A ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c SCARBOROUGH HOSPITAL   (Canada)

Author keywords

Abetalipoproteinemia; Acanthocytes; Apolopoprotein B; Intestinal neoplasia; Retinitis pigmentosa

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; LOW DENSITY LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; RETINOL; VITAMIN K GROUP;

ABETALIPOPROTEINEMIA; ACANTHOCYTOSIS; ADENOCARCINOMA; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; ILEUM CANCER; LIPID ABSORPTION; MALABSORPTION; MALE; MISSENSE MUTATION; NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SECRETION; RETINITIS PIGMENTOSA; SURVIVAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ABETALIPOPROTEINEMIA; ADENOCARCINOMA; CARRIER PROTEINS; HUMANS; ILEAL NEOPLASMS; MALE; MIDDLE AGED; MUTATION, MISSENSE;

EID: 0041630959     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0009-9163.2002.00175.x     Document Type: Article

References (24)

1. Gregg RE, Wetterau JR. The molecular basis of abetalipoproteinemia. Curr Opin Lipidol 1994: 5: 81-86.
2. Sharp P, Blinderman L, Combs KA et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinemia. Nature 1993: 365: 65-69.
3. Shoulders CC, Brett DJ, Bayliss JD et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet 1993: 2: 2109-2116.
4. Narcisi TME, Shoulders CC, Chester SA et al. Mutations of the microsomal triglyceride transfer protein gene in abetalipoproteinemia. Am J Hum Genet 1995: 57: 1298-1310.
5. Ricci B, Sharp D, O'Rourde E et al. A 30-amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfide-isomerase and causes abetalipoproteinemia. J Biol Chem 1995: 270: 14281-14285.
6. Yang XP, Inazu A, Yagi K, Kajinami K, Koizumi J, Mabuchi H. Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene. Arterioscler Thromb Vasc Biol 1999: 19: 1950-1955.
7. Wang J, Hegele RA. Microsomal triglyceride transfer protein (MTP) gene mutations in Canadian subjects with abetalipoproteinemia. Hum Mutat 2000: 15: 294-295.
8. Ohashi K, Ishibashi S, Osuga J et al. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J Lipid Res 2000: 41: 1199-1204.
9. Wetterau JR, Combs KA, Spinner SN, Joiner BJ. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J Biol Chem 1990: 265: 9800-9807.
10. Davis R, Thrift RN, Wu CC, Howell KE. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. J Biol Chem 1990: 265: 10005-10011.
11. Boren J, Wettesten M, Sjoberg A et al. The assembly and secretion of apo B-100 containing lipoproteins in HepG2 cells. J Biol Chem 1990: 265: 10556-10564.
12. Leiper J, Bayliss JD, Pease RJ, Brett DJ, Scott J, Shoulders CC. Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells. J Biol Chem 1994: 269: 21951-21954.
13. Gordon D, Jamil H, Sharp D et al. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability Proc Natl Acad Sci USA 1994: 91: 7628-7632.
14. Bradbury P, Mann CJ, Kochl S et al. A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase. J Biol Chem 1999: 274: 3159-3164.
15. Kayden HJ. Is essential fatty acid deficiency part of the syndrome of abetalipoproteinemia? Nutr Rev 1980: 38: 244-246.
16. Sperling MA, Hengstenberg F, Yunis E, Kenny FM, Drash AL. Abetalipoproteinemia. metabolic, endocrine, and electron-microscopic investigations. Pediatrics 1971: 48: 91-102.
17. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma ME, Wetterau JR. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000: 20: 663-697.
18. Kayden HJ, Silber R. The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis. Trans Assoc Am Phys 1965: 78: 334-342.
19. Hegele RA, Angel AA. Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy. Can Med Assoc J 1985: 132: 41-44.
20. Wolff OH, Lloyd JK, Tonks EL. Abetalipoproteinemia, with special reference to the visual defect. Exp Eye Res 1964: 3: 439-442.
21. Delpre G, Kadish U, Glantz I, Avidor I. Endoscopic assessment in abetalipoproteinemia. Endoscopy 1978: 10: 59-62.
22. Hamid AM, Ghamande SA, Kasznica J. Adenocarcinoma of the ileum with an enterotubal fistula presenting as an adnexal mass. Gynecol Oncol 1997: 64: 270-273.
23. Shiomi M, Ito T. MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion. Euro J Pharmacol 2001: 431: 127-131.
24. Robl JA, Sulsky R, Sun CQ, Simpkins LM, Wang T et al. A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors. J Med Chem 2001: 44: 851-856.